Clinical Trial Update: Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating fingolimod with fish oil in relapsing-remitting multiple sclerosis has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fingolimod (fingolimod)
• Fish oil

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-05-14